基本情報
- 標準SMILES
O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl- InChIKey
AGHANLSBXUWXTB-UHFFFAOYSA-N- 分子式
- C13H8Cl2O4S
- 平均分子量
- 331.2 g/mol
- 単同位体質量
- 329.9520351
概要
Tienilic acid is an aromatic ketone that is 2,3-dichlorophenoxyacetic acid in which the hydrogen at position 4 on the benzene ring is replaced by a thiophenecarbonyl group. A loop diuretic used to treat hypertension, it was withdrawn from the market in 1982 due to links with hepatitis. It has a role as an antihypertensive agent, a hepatotoxic agent and a loop diuretic. It is a dichlorobenzene, a monocarboxylic acid, a member of thiophenes, an aromatic ether and an aromatic ketone.
名称と識別子
- 優先名称
- Tienilic Acid
- IUPAC
- 2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid
- 現地名
- チクリナフェン
- 英語名
- TICRYNAFEN
- 分子式
- C13H8Cl2O4S
- 分子量
- 331.17
名称と別名
名称をさらに表示
データベース識別子
- CAS
40180-04-9- PubChem CID
- 38409
- DTXSID
DTXSID4023670- ChEMBL
CHEMBL267744- ChEBI
CHEBI:9590- UNII
- HC95205SY4
- EC Number
- 254-826-3
- Nikkaji
- J16.869F
物性
構造計算による物性
- XLogP
- 4.1
- 極性表面積
- 91.8 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 5
- 回転可能結合数
- 5
- 重原子数
- 20
- 形式電荷
- 0
- 複雑度
- 379
実験および物理化学的性質
物理化学的性質
- 融点
- 148 · 148-149oC
- 沸点
- 534.6 · 534.6±50.0 °C(Predicted)
- 比重(密度)
- 1.532 · 1.532
- 貯蔵温度
- -20 °C · -20°C
- 溶解性
- 5 mg/mL · DMSO:ソリュブル5mg/mL(透明溶液)
- 酸解離定数(Pka)
- 2.79 · 2.79±0.10(Predicted)
- 外見
- 粉
- 色
- 白からベージュ
- InChI
- InChI=1S/C13H8Cl2O4S/c14-11-7(13(18)9-2-1-5-20-9)3-4-8(12(11)15)19-6-10(16)17/h1-5H,6H2,(H,16,17)
- InChIKey
- AGHANLSBXUWXTB-UHFFFAOYSA-N
- SMILES
- C(O)(=O)COC1=CC=C(C(C2SC=CC=2)=O)C(Cl)=C1Cl
化学的性質
化学的特性Pale Beige Solid
安全と法規制
GHS分類
GHS Classification
Warning
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
危険有害性情報
毒性情報
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Ticrynafen
vMost-DILI-concern
8
Withdrawn
DOI:10.1016/j.drudis.2016.02.015
安全データ
- wgk
- 3
- rtecs
- AG9300000
- 毒性
- LD50 in mice (mg/kg): 225 i.v., 1275 orally (US 3758506)
- risk_code
- 22
- hazard_code
- Xn
- ストレージクラス
- 11 - Combustible Solids
化学と産業
薬理情報
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
MeSH Pharmacological Classification
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Agents that promote the excretion of urine through their effects on kidney function.
Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma.
応用分野
使用A heterocycloc derivative of phenoxyacetic Acid. Uses as a diuretic, uricosuric, anhtihypertensive
サプライヤー50 社
補足説明
定義ChEBI: An aromatic ketone that is 2,3-dichlorophenoxyacetic acid in which the hydrogen at position 4 on the benzene ring is replaced by a thiophenecarbonyl group. A loop diuretic used to treat hypertension, it was withdrawn from the market in 1982 due to links wi h hepatitis.
関連反応
関連ノート
読み込み中…